HM Payson & Co’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-17,651
Closed -$1.42M 355
2016
Q4
$1.42M Sell
17,651
-12,132
-41% -$963K 0.07% 160
2016
Q3
$2.38M Sell
29,783
-6,760
-18% -$546K 0.12% 129
2016
Q2
$2.85M Sell
36,543
-779
-2% -$55.5K 0.14% 116
2016
Q1
$2.05M Sell
37,322
-749
-2% -$40.8K 0.11% 128
2015
Q4
$2.35M Sell
38,071
-460
-1% -$29K 0.12% 132
2015
Q3
$2.43M Hold
38,531
0.13% 125
2015
Q2
$2.82M Sell
38,531
-250
-0.6% -$18.1K 0.14% 123
2015
Q1
$2.54M Sell
38,781
-994
-2% -$66.1K 0.13% 124
2014
Q4
$2.59M Hold
39,775
0.13% 123
2014
Q3
$2.39M Sell
39,775
-240
-0.6% -$15.7K 0.12% 123
2014
Q2
$2.77M Sell
40,015
-92
-0.2% -$5.96K 0.14% 116
2014
Q1
$2.62M Sell
40,107
-1,120
-3% -$72.9K 0.14% 119
2013
Q4
$2.55M Sell
41,227
-2,940
-7% -$170K 0.14% 121
2013
Q3
$2.37M Sell
44,167
-1,550
-3% -$79.8K 0.14% 120
2013
Q2
$2.09M Buy
+45,717
New +$1.98M 0.13% 126

Other funds holding STJ

HM Payson & Co's STJ Position: Q1 2017 in Review

HM Payson & Co sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 17,651 shares — an estimated $1.42M sold.

HM Payson & Co first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $2.85M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • HM Payson & Co reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • HM Payson & Co sold 17,651 St Jude Medical shares in Q1 2017, an estimated $1.42M.
  • HM Payson & Co first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • HM Payson & Co's St Jude Medical position peaked at $2.85M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on HM Payson & Co's 13F filing for Q1 2017, filed 25 May 2017.